#aafth ,,congress #b;d ,session ,s4 #bjcb ,,an ,,act ,to expand research on the cannabidiol and marihuana4 #a4 ,short title2 table of contents 7a7 ,short title ,this ,act may be cited as the ,cannabidiol and ,marihuana ,research ,expansion ,act4 7b7 ,table of contents ,the table of contents for this ,act is as follows3 ,sec4 #a4 ,short title2 table of contents4,sec4 #b4 ,definitions4,,title ,i--,registrations for marihuana research,sec4 #aja4 ,marihuana research applications4,sec4 #ajb4 ,research protocols4,sec4 #ajc4 ,applications to manufacture marihuana for research4,sec4 #ajd4 ,adequate and uninterrupted supply4,sec4 #aje4 ,security requirements4,sec4 #ajf4 ,prohibition against reinstating interdisciplinary review process for non-,,nih funded researchers4,,title ,,ii--,development of ,,fda-approved drugs using cannabidiol and marihuana,sec4 #bja4 ,medical research on cannabidiol4,sec4 #bjb4 ,registration for the commercial production and distribution of ,food and ,drug ,administration approved drugs4,sec4 #bjc4 ,importation of cannabidiol for research purposes4,,title ,,iii--,doctor-patient relationship,sec4 #cja4 ,doctor-patient relationship4,,title ,,iv--,federal research,sec4 #dja4 ,federal research4 #b4 ,definitions ,in this ,act-- 7#a7 the term appropriately registered means that an individual or entity is registered under the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 to engage in the type of activity that is carried out by the individual or entity with respect to a controlled substance on the schedule that is applicable to cannabidiol or marihuana1 as applicable2 7#b7 the term cannabidiol means-- 7,a7 the substance1 cannabidiol1 as derived from marihuana that has a delta-#i tetrahydrocannabinol level that is greater than #j4c percent2 and 7,b7 the synthetic equivalent of the substance described in subparagraph 7,a72 7#c7 the terms controlled substance1 dispense1 distribute1 manufacture1 marihuana1 and practitioner have the meanings given such terms in section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb71 as amended by this ,act2 7#d7 the term covered institution of higher education means an institution of higher education 7as defined in section #aja of the ,higher ,education ,act of #aife 7#bj ,u4,s4,c4 #ajja77 that-- 7,a7 7i7 has highest or higher research activity1 as defined by the ,carnegie ,classification of ,institutions of ,higher ,education2 or 7ii7 is an accredited medical school or an accredited school of osteopathic medicine2 and 7,b7 is appropriately registered under the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq472 7#e7 the term drug has the meaning given the term in section #bja7;g77#a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cba7;g77#a772 7#f7 the term medical research for drug development means medical research that is-- 7,a7 a preclinical study or clinical investigation conducted in accordance with section #eje7;i7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;i77 or otherwise permitted by the ,department of ,health and ,human ,services to determine the potential medical benefits of marihuana or cannabidiol as a drug2 and 7,b7 conducted by a covered institution of higher education1 practitioner1 or manufacturer that is appropriately registered under the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq472 and 7#g7 the term ,state means any ,state of the ,united ,states1 the ,district of ,columbia1 and any territory of the ,united ,states4 ,i ,registrations for marihuana research #aja4 ,marihuana research applications ,section #cjc7;f7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;f77 is amended-- 7#a7 by redesignating paragraphs 7#a7 through 7#e7 as subparagraphs 7,a7 through 7,e71 respectively2 7#b7 by striking 7f7 ,the ,attorney ,general and inserting 7f77#a7 ,the ,attorney ,general2 7#c7 by striking ,registration applications and inserting the following3 7#b7 7,a7 ,registration applications 2 7#d7 by striking ,article #g and inserting the following3 7#c7 ,article #g 2 and 7#e7 by inserting after paragraph 7#b77;,a71 as so designated1 the following3 7,b7 7i7 ,the ,attorney ,general shall register a practitioner to conduct research with marihuana if-- 7,i7 the applicant's research protocol-- 7aa7 has been reviewed and allowed-- 7,,aa7 by the ,secretary of ,health and ,human ,services under section #eje7;i7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;i772 7,,bb7 by the ,national ,institutes of ,health or another ,federal agency that funds scientific research2 or 7,,cc7 pursuant to sections #acja4ah and #acja4cb of title #ba1 ,code of ,federal ,regulations1 or any successors thereto2 and 7,,ii7 the applicant has demonstrated to the ,attorney ,general that there are effective procedures in place to adequately safeguard against diversion of the controlled substance for legitimate medical or scientific use pursuant to section #aje of the ,cannabidiol and ,marihuana ,research ,expansion ,act1 including demonstrating that the security measures are adequate for storing the quantity of marihuana the applicant would be authorized to possess4 7ii7 ,the ,attorney ,general may deny an application for registration under this subparagraph only if the ,attorney ,general determines that the issuance of the registration would be inconsistent with the public interest4 ,in determining the public interest1 the ,attorney ,general shall consider the factors listed in-- 7,i7 subparagraphs 7,b7 through 7,e7 of paragraph 7#a72 and 7,,ii7 subparagraph 7,a7 of paragraph 7#a71 if the applicable ,state requires practitioners conducting research to register with a board or authority described in such subparagraph 7,a74 7iii7 7,i7 ,not later than #fj days after the date on which the ,attorney ,general receives a complete application for registration under this subparagraph1 the ,attorney ,general shall-- 7aa7 approve the application2 or 7bb7 request supplemental information4 7,,ii7 ,for purposes of subclause 7,i71 an application shall be deemed complete when the applicant has submitted documentation showing that the requirements under clause 7i7 are satisfied4 7iv7 ,not later than #cj days after the date on which the ,attorney ,general receives supplemental information as described in clause 7iii77,i77bb7 in connection with an application described in this subparagraph1 the ,attorney ,general shall approve or deny the application4 7v7 ,if an application described in this subparagraph is denied1 the ,attorney ,general shall provide a written explanation of the basis of denial to the applicant4 4 #ajb4 ,research protocols 7a7 ,in general ,paragraph 7#b77;,b7 of section #cjc7;f7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;f771 as amended by section #aja of this ,act1 is further amended by adding at the end the following3 7vi7 7,i7 ,if the ,attorney ,general grants an application for registration under clause 7i71 the registrant may amend or supplement the research protocol without reapplying if the registrant does not change-- 7aa7 the quantity or type of drug2 7bb7 the source of the drug2 or 7cc7 the conditions under which the drug is stored1 tracked1 or administered4 7,,ii7 7aa7 ,if a registrant under clause 7i7 seeks to change the type of drug1 the source of the drug1 or conditions under which the drug is stored1 tracked1 or administered1 the registrant shall notify the ,attorney ,general via registered mail1 or an electronic means permitted by the ,attorney ,general1 not later than #cj days before implementing an amended or supplemental research protocol4 7bb7 ,a registrant may proceed with an amended or supplemental research protocol described in item 7aa7 if the ,attorney ,general does not explicitly object during the #cj-;day period beginning on the date on which the ,attorney ,general receives the notice under item 7aa74 7cc7 ,the ,attorney ,general may only object to an amended or supplemental research protocol under this subclause if additional security measures are needed to safeguard against diversion or abuse4 7dd7 ,if a registrant under clause 7i7 seeks to address additional security measures identified by the ,attorney ,general under item 7cc71 the registrant shall notify the ,attorney ,general via registered mail1 or an electronic means permitted by the ,attorney ,general1 not later than #cj days before implementing an amended or supplemental research protocol4 7ee7 ,a registrant may proceed with an amended or supplemental research protocol described in item 7dd7 if the ,attorney ,general does not explicitly object during the #cj-;day period beginning on the date on which the ,attorney ,general receives the notice under item 7dd74 7,,iii7 7aa7 ,if a registrant under clause 7i7 seeks to change the quantity of marihuana needed for research and the change in quantity does not impact the factors described in item 7bb7 or 7cc7 of subclause 7,i7 of this clause1 the registrant shall notify the ,attorney ,general via registered mail or using an electronic means permitted by the ,attorney ,general4 7bb7 ,a notification under item 7aa7 shall include-- 7,,aa7 the ,drug ,enforcement ,administration registration number of the registrant2 7,,bb7 the quantity of marihuana already obtained2 7,,cc7 the quantity of additional marihuana needed to complete the research2 and 7,,dd7 an attestation that the change in quantity does not impact the source of the drug or the conditions under which the drug is stored1 tracked1 or administered4 7cc7 ,the ,attorney ,general shall ensure that-- 7,,aa7 any registered mail return receipt with respect to a notification under item 7aa7 is submitted for delivery to the registrant providing the notification not later than #c days after receipt of the notification by the ,attorney ,general2 and 7,,bb7 notice of receipt of a notification using an electronic means permitted under item 7aa7 is provided to the registrant providing the notification not later than #c days after receipt of the notification by the ,attorney ,general4 7dd7 7,,aa7 ,on and after the date described in subitem 7,,bb71 a registrant that submits a notification in accordance with item 7aa7 may proceed with the research as if the change in quantity has been approved on such date1 unless the ,attorney ,general notifies the registrant of an objection described in item 7ee74 7,,bb7 ,the date described in this subitem is the date on which a registrant submitting a notification under item 7aa7 receives the registered mail return receipt with respect to the notification or the date on which the registrant receives notice that the notification using an electronic means permitted under item 7aa7 was received by the ,attorney ,general1 as the case may be4 7ee7 ,a notification submitted under item 7aa7 shall be deemed to be approved unless the ,attorney ,general1 not later than #aj days after receiving the notification1 explicitly objects based on a finding that the change in quantity-- 7,,aa7 does impact the source of the drug or the conditions under which the drug is stored1 tracked1 or administered2 or 7,,bb7 necessitates that the registrant implement additional security measures to safeguard against diversion or abuse4 7,,iv7 ,nothing in this clause shall limit the authority of the ,secretary of ,health and ,human ,services over requirements related to research protocols1 including changes in-- 7aa7 the method of administration of marihuana2 7bb7 the dosing of marihuana2 and 7cc7 the number of individuals or patients involved in research4 4 7b7 ,regulations ,not later than #a year after the date of enactment of this ,act1 the ,attorney ,general shall promulgate regulations to carry out the amendment made by this section4 #ajc4 ,applications to manufacture marihuana for research 7a7 ,in general ,section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7 is amended-- 7#a7 by redesignating subsections 7c7 through 7k7 as subsections 7d7 through 7l71 respectively2 7#b7 by inserting after subsection 7b7 the following3 7c7 7#a7 7,a7 ,as it relates to applications to manufacture marihuana for research purposes1 if the ,attorney ,general places a notice in the ,federal ,register to increase the number of entities registered under this ,act to manufacture marihuana to supply appropriately registered researchers in the ,united ,states1 the ,attorney ,general shall1 not later than #fj days after the date on which the ,attorney ,general receives a completed application-- 7i7 approve the application2 or 7ii7 request supplemental information4 7,b7 ,for purposes of subparagraph 7,a71 an application shall be deemed complete when the applicant has submitted documentation showing each of the following3 7i7 ,the requirements designated in the notice in the ,federal ,register are satisfied4 7ii7 ,the requirements under this ,act are satisfied4 7iii7 ,the applicant will limit the transfer and sale of any marihuana manufactured under this subsection-- 7,i7 to researchers who are registered under this ,act to conduct research with controlled substances in schedule ,i2 and 7,,ii7 for purposes of use in preclinical research or in a clinical investigation pursuant to an investigational new drug exemption under #eje7;i7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;i774 7iv7 ,the applicant will transfer or sell any marihuana manufactured under this subsection only with prior1 written consent for the transfer or sale by the ,attorney ,general4 7v7 ,the applicant has completed the application and review process under subsection 7a7 for the bulk manufacture of controlled substances in schedule ,i4 7vi7 ,the applicant has established and begun operation of a process for storage and handling of controlled substances in schedule ,i1 including for inventory control and monitoring security in accordance with section #aje of the ,cannabidiol and ,marihuana ,research ,expansion ,act4 7vii7 ,the applicant is licensed by each ,state in which the applicant will conduct operations under this subsection1 to manufacture marihuana1 if that ,state requires such a license4 7,c7 ,not later than #cj days after the date on which the ,attorney ,general receives supplemental information requested under subparagraph 7,a77ii7 with respect to an application1 the ,attorney ,general shall approve or deny the application4 7#b7 ,if an application described in this subsection is denied1 the ,attorney ,general shall provide a written explanation of the basis of denial to the applicant4 2 7#c7 in subsection 7h77#b71 as so redesignated1 by striking subsection 7f7 each place it appears and inserting subsection 7g72 7#d7 in subsection 7j77#a71 as so redesignated1 by striking subsection 7d7 and inserting subsection 7e72 and 7#e7 in subsection 7k71 as so redesignated1 by striking subsection 7f7 each place it appears and inserting subsection 7g74 7b7 ,technical and conforming amendments 7#a7 ,the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 is amended-- 7,a7 in section #ajb 7#ba ,u4,s4,c4 #hjb7-- 7i7 in paragraph 7#af77;,b7-- 7,i7 in clause 7i71 by striking or at the end2 7,,ii7 by redesignating clause 7ii7 as 7iii72 and 7,,iii7 by inserting after clause 7i7 the following3 7ii7 the synthetic equivalent of hemp-derived cannabidiol that contains less than #j4c percent tetrahydrocannabinol2 or 2 7ii7 in paragraph 7#eb77;,b7-- 7,i7 by striking #cjc7;f7 each place it appears and inserting #cjc7;g72 and 7,,ii7 in clause 7i71 by striking 7d71 or 7e7 and inserting 7e71 or 7f72 and 7iii7 in paragraph 7#ed71 by striking #cjc7;f7 each place it appears and inserting #cjc7;g72 7,b7 in section #cjb7;g77#e77;,a77iii77,i77bb7 7#ba ,u4,s4,c4 #hbb7;g77#e77;,a77iii77,i77bb771 by striking #cjc7;f7 and inserting #cjc7;g72 7,c7 in section #cjd 7#ba ,u4,s4,c4 #hbd71 by striking #cjc7;g77#a7 each place it appears and inserting #cjc7;h77#a72 7,d7 in section #cjg7;d77#b7 7#ba ,u4,s4,c4 #hbg7;d77#b771 by striking #cjc7;f7 and inserting #cjc7;g72 7,e7 in section #cji;,a7a77#b7 7#ba ,u4,s4,c4 #hbi;a7a77#b771 in the matter preceding subparagraph 7,a71 by striking #cjc7;g77#b7 and inserting #cjc7;h77#b72 7,f7 in section #caa7;h7 7#ba ,u4,s4,c4 #hca7;h771 by striking #cjc7;f7 each place it appears and inserting #cjc7;g72 7,g7 in section #dja7;h77#b7 7#ba ,u4,s4,c4 #hda7;h77#b771 by striking #cjc7;f7 each place it appears and inserting #cjc7;g72 7,h7 in section #djc7;c77#b77;,b7 7#ba ,u4,s4,c4 #hdc7;c77#b77;,b771 by striking #cjc7;f7 and inserting #cjc7;g72 and 7,i7 in section #eab7;c77#a7 7#ba ,u4,s4,c4 #hhb7;c77#a77 by striking #cjc7;f7 and inserting #cjc7;g74 7#b7 ,section #ajjh7;c7 of the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #ieh7;c77 is amended-- 7,a7 in paragraph 7#a71 by striking #cjc7;d7 and inserting #cjc7;e72 and 7,b7 in paragraph 7#b77;,b71 by striking #cjc7;h7 and inserting #cjc7;i74 7#c7 ,title ,v of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;aa et seq47 is amended-- 7,a7 in section #ebj;,e-#d7;c7 7#db ,u4,s4,c4 #bij;bb-#cf;d7c771 by striking #cjc7;g77#b77;,b7 and inserting #cjc7;h77#b77;,b72 and 7,b7 in section #edd7;a77#c7 7#db ,u4,s4,c4 #bij;dd-#c7;a77#c771 by striking #cjc7;g7 and inserting #cjc7;h74 7#d7 ,title ,,xviii of the ,social ,security ,act 7#db ,u4,s4,c4 #acie et seq47 is amended-- 7,a7 in section #ahcc7;bb77#c77;,b7 7#db ,u4,s4,c4 #aciel7bb77#c77;,b771 by striking #cjc7;g7 and inserting #cjc7;h72 7,b7 in section #ahcd7o77#c77;,c77ii7 7#db ,u4,s4,c4 #aciem7o77#c77;,c77ii771 by striking #cjc7;g7 and inserting #cjc7;h72 and 7,c7 in section #ahff;,f7c77#c77;,c7 7#db ,u4,s4,c4 #acie;cc-#f7;c77#c77;,c771 by striking #cjc7;g7 and inserting #cjc7;h74 7#e7 ,section #aijc7;aa77#b77;,c77ii7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;b7aa77#b77;,c77ii77 is amended by striking #cjc7;g7 each place it appears and inserting #cjc7;h74 #ajd4 ,adequate and uninterrupted supply ,on an annual basis1 the ,attorney ,general shall assess whether there is an adequate and uninterrupted supply of marihuana1 including of specific strains1 for research purposes4 #aje4 ,security requirements 7a7 ,in general ,an individual or entity engaged in researching marihuana or its components shall store it in a securely locked1 substantially constructed cabinet4 7b7 ,requirements for other measures ,any other security measures required by the ,attorney ,general to safeguard against diversion shall be consistent with those required for practitioners conducting research on other controlled substances in schedules ,i and ,,ii in section #bjb7;c7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab7;c77 that have a similar risk of diversion and abuse4 #ajf4 ,prohibition against reinstating interdisciplinary review process for non-,,nih funded researchers ,the ,secretary of ,health and ,human ,services may not-- 7#a7 reinstate the ,public ,health ,service interdisciplinary review process described in the guidance entitled ,guidance on ,procedures for the ,provision of ,marijuana for ,medical ,research 7issued on ,may #ba1 #aiii72 or 7#b7 require another review of scientific protocols that is applicable only to research on marihuana or its components4 ,,ii ,development of ,,fda-approved drugs using cannabidiol and marihuana #bja4 ,medical research on cannabidiol ,notwithstanding any provision of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq471 the ,safe and ,drug-,free ,schools and ,communities ,act 7#bj ,u4,s4,c4 #gaja et seq471 chapter #ha of title #da1 ,united ,states ,code1 or any other ,federal law1 an appropriately registered covered institution of higher education1 a practitioner1 or a manufacturer may manufacture1 distribute1 dispense1 or possess marihuana or cannabidiol if the marihuana or cannabidiol is manufactured1 distributed1 dispensed1 or possessed1 respectively1 for purposes of medical research for drug development or subsequent commercial production in accordance with section #bjb4 #bjb4 ,registration for the commercial production and distribution of ,food and ,drug ,administration approved drugs ,the ,attorney ,general shall register an applicant to manufacture or distribute cannabidiol or marihuana for the purpose of commercial production of a drug containing or derived from marihuana that is approved by the ,secretary of ,health and ,human ,services under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee71 in accordance with the applicable requirements under subsection 7a7 or 7b7 of section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc74 #bjc4 ,importation of cannabidiol for research purposes ,the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #iea et seq47 is amended-- 7#a7 in section #ajjb7;a7 7#ba ,u4,s4,c4 #ieb7;a77-- 7,a7 in paragraph 7#a71 by striking and at the end2 7,b7 in paragraph 7#b77;,c71 by inserting and after uses12 and 7,c7 inserting before the undesignated matter following paragraph 7#b77;,c7 the following3 7#c7 such amounts of marihuana or cannabidiol 7as defined in section #b of the ,cannabidiol and ,marihuana ,research ,expansion ,act7 as are-- 7,a7 approved for medical research for drug development 7as such terms are defined in section #b of the ,cannabidiol and ,marihuana ,research ,expansion ,act71 or 7,b7 necessary for registered manufacturers to manufacture drugs containing marihuana or cannabidiol that have been approved for use by the ,commissioner of ,food and ,drugs under the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq471 2 and 7#b7 in section #ajjg 7#ba ,u4,s4,c4 #ieg71 by amending subsection 7a7 to read as follows3 7a7 7#a7 ,except as provided in paragraph 7#b71 no person may-- 7,a7 import into the customs territory of the ,united ,states from any place outside thereof 7but within the ,united ,states71 or import into the ,united ,states from any place outside thereof1 any controlled substance or list ,i chemical1 or 7,b7 export from the ,united ,states any controlled substance or list ,i chemical1 unless there is in effect with respect to such person a registration issued by the ,attorney ,general under section #ajjh1 or unless such person is exempt from registration under subsection 7b74 7#b7 ,paragraph 7#a7 shall not apply to the import or export of marihuana or cannabidiol 7as defined in section #b of the ,cannabidiol and ,marihuana ,research ,expansion ,act7 that has been approved for-- 7,a7 medical research for drug development authorized under section #bja of the ,cannabidiol and ,marihuana ,research ,expansion ,act2 or 7,b7 use by registered manufacturers to manufacture drugs containing marihuana or cannabidiol that have been approved for use by the ,commissioner of ,food and ,drugs under the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq474 4 ,,iii ,doctor-patient relationship #cja4 ,doctor-patient relationship ,it shall not be a violation of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 for a ,state-licensed physician to discuss-- 7#a7 the currently known potential harms and benefits of marihuana derivatives1 including cannabidiol1 as a treatment with the legal guardian of the patient of the physician if the patient is a child2 or 7#b7 the currently known potential harms and benefits of marihuana and marihuana derivatives1 including cannabidiol1 as a treatment with the patient or the legal guardian of the patient of the physician if the patient is a legal adult4 ,,iv ,federal research #dja4 ,federal research 7a7 ,in general ,not later than #a year after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 in coordination with the ,director of the ,national ,institutes of ,health and the heads of other relevant ,federal agencies1 shall submit to the ,caucus on ,international ,narcotics ,control1 the ,committee on the ,judiciary1 and the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce and the ,committee on the ,judiciary of the ,house of ,representatives a report on-- 7#a7 the potential therapeutic effects of cannabidiol or marihuana on serious medical conditions1 including intractable epilepsy2 7#b7 the potential effects of marihuana1 including-- 7,a7 the effect of increasing delta-#i-tetrahydrocannabinol levels on the human body and developing adolescent brains2 and 7,b7 the effect of various delta-#i-tetrahydrocannabinol levels on cognitive abilities1 such as those that are required to operate motor vehicles or other heavy equipment2 and 7#c7 the barriers associated with researching marihuana or cannabidiol in ,states that have legalized the use of such substances1 which shall include-- 7,a7 recommendations as to how such barriers might be overcome1 including whether public-private partnerships or ,federal-,state research partnerships may or should be implemented to provide researchers with access to additional strains of marihuana and cannabidiol2 and 7,b7 recommendations as to what safeguards must be in place to verify-- 7i7 the levels of tetrahydrocannabinol1 cannabidiol1 or other cannabinoids contained in products obtained from such ,states is accurate2 and 7ii7 that such products do not contain harmful or toxic components4 7b7 ,activities ,to the extent practicable1 the ,secretary of ,health and ,human ,services1 either directly or through awarding grants1 contacts1 or cooperative agreements1 shall expand and coordinate the activities of the ,national ,institutes of ,health and other relevant ,federal agencies to better determine the effects of cannabidiol and marihuana1 as outlined in the report submitted under paragraphs 7#a7 and 7#b7 of subsection 7a74 ,passed the ,senate ,december #ae1 #bjbj4,secretary